APO Research
Talk to an analyst

APO RESEARCH · REPORT

Progressive Supranuclear Palsy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Progressive Supranuclear Palsy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025197 pages

Choose your research edition.

Industry ResearchProgressive Supranuclear Palsy Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Progressive Supranuclear Palsy Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Progressive Supranuclear Palsy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Progressive Supranuclear Palsy Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Progressive Supranuclear Palsy Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Progressive Supranuclear Palsy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Progressive Supranuclear Palsy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Progressive Supranuclear Palsy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Progressive Supranuclear Palsy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Progressive Supranuclear Palsy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Progressive Supranuclear Palsy include Novartis AG, Merck & Co., Inc., GlaxoSmithKline plc, Biogen Inc., Bristol Myers Squibb (BMS), AbbVie Inc., Acorda Therapeutics Inc., Teva Pharmaceutical Industries Ltd. and Cortice Biosciences, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Progressive Supranuclear Palsy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Progressive Supranuclear Palsy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Progressive Supranuclear Palsy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Progressive Supranuclear Palsy market size, projected growth trends, production technologies, key applications, and end-use industries.

Progressive Supranuclear Palsy Segment by Company

Novartis AG

Merck & Co., Inc.

GlaxoSmithKline plc

Biogen Inc.

Bristol Myers Squibb (BMS)

AbbVie Inc.

Acorda Therapeutics Inc.

Teva Pharmaceutical Industries Ltd.

Cortice Biosciences, Inc.

Aton Pharma, Inc.

AlzProtect SAS

AB Science

Progressive Supranuclear Palsy Segment by Type

Late Stage

Clinical Trial

Early Stage

Others

Progressive Supranuclear Palsy Segment by Application

Clinics

Hospitals

Research Institutes

Others

Progressive Supranuclear Palsy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Progressive Supranuclear Palsy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Progressive Supranuclear Palsy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Progressive Supranuclear Palsy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Progressive Supranuclear Palsy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Progressive Supranuclear Palsy industry.

Chapter 3: Detailed analysis of Progressive Supranuclear Palsy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Progressive Supranuclear Palsyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Progressive Supranuclear Palsy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Late Stage Table 3. Key Players of Clinical Trial Table 4. Key Players of Early Stage Table 3. Key Players of Others Table 4. Global Progressive Supranuclear Palsy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Clinics Table 6. Key Players of Hospitals Table 7. Key Players of Research Institutes Table 8. Key Players of Others Table 9. Global Progressive Supranuclear Palsy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Progressive Supranuclear Palsy Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Progressive Supranuclear Palsy Market Share by Region (2021-2026) Table 12. Global Progressive Supranuclear Palsy Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Progressive Supranuclear Palsy Market Share by Region (2027-2032) Table 14. Progressive Supranuclear Palsy Industry Trends Table 15. Progressive Supranuclear Palsy Industry Drivers Table 16. Progressive Supranuclear Palsy Industry Opportunities and Challenges Table 17. Progressive Supranuclear Palsy Industry Restraints Table 18. Global Progressive Supranuclear Palsy Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Progressive Supranuclear Palsy Revenue Market Share by Company (2021-2026) Table 20. Global Progressive Supranuclear Palsy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Progressive Supranuclear Palsy Key Company Head Office and Area Served Table 22. Global Progressive Supranuclear Palsy Company, Product Type & Application Table 23. Global Progressive Supranuclear Palsy Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Progressive Supranuclear Palsy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Progressive Supranuclear Palsy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Progressive Supranuclear Palsy Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Progressive Supranuclear Palsy Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Progressive Supranuclear Palsy Revenue Market Share by Type (2021-2026) Table 30. Global Progressive Supranuclear Palsy Revenue Market Share by Type (2027-2032) Table 31. Global Progressive Supranuclear Palsy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Progressive Supranuclear Palsy Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Progressive Supranuclear Palsy Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Progressive Supranuclear Palsy Revenue Market Share by Application (2021-2026) Table 35. Global Progressive Supranuclear Palsy Revenue Market Share by Application (2027-2032) Table 36. Novartis AG Company Information Table 37. Novartis AG Business Overview Table 38. Novartis AG Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Novartis AG Progressive Supranuclear Palsy Product Portfolio Table 40. Novartis AG Recent Development Table 41. Merck & Co., Inc. Company Information Table 42. Merck & Co., Inc. Business Overview Table 43. Merck & Co., Inc. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Merck & Co., Inc. Progressive Supranuclear Palsy Product Portfolio Table 45. Merck & Co., Inc. Recent Development Table 46. GlaxoSmithKline plc Company Information Table 47. GlaxoSmithKline plc Business Overview Table 48. GlaxoSmithKline plc Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. GlaxoSmithKline plc Progressive Supranuclear Palsy Product Portfolio Table 50. GlaxoSmithKline plc Recent Development Table 51. Biogen Inc. Company Information Table 52. Biogen Inc. Business Overview Table 53. Biogen Inc. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Biogen Inc. Progressive Supranuclear Palsy Product Portfolio Table 55. Biogen Inc. Recent Development Table 56. Bristol Myers Squibb (BMS) Company Information Table 57. Bristol Myers Squibb (BMS) Business Overview Table 58. Bristol Myers Squibb (BMS) Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Bristol Myers Squibb (BMS) Progressive Supranuclear Palsy Product Portfolio Table 60. Bristol Myers Squibb (BMS) Recent Development Table 61. AbbVie Inc. Company Information Table 62. AbbVie Inc. Business Overview Table 63. AbbVie Inc. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. AbbVie Inc. Progressive Supranuclear Palsy Product Portfolio Table 65. AbbVie Inc. Recent Development Table 66. Acorda Therapeutics Inc. Company Information Table 67. Acorda Therapeutics Inc. Business Overview Table 68. Acorda Therapeutics Inc. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Acorda Therapeutics Inc. Progressive Supranuclear Palsy Product Portfolio Table 70. Acorda Therapeutics Inc. Recent Development Table 71. Teva Pharmaceutical Industries Ltd. Company Information Table 72. Teva Pharmaceutical Industries Ltd. Business Overview Table 73. Teva Pharmaceutical Industries Ltd. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Teva Pharmaceutical Industries Ltd. Progressive Supranuclear Palsy Product Portfolio Table 75. Teva Pharmaceutical Industries Ltd. Recent Development Table 76. Cortice Biosciences, Inc. Company Information Table 77. Cortice Biosciences, Inc. Business Overview Table 78. Cortice Biosciences, Inc. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Cortice Biosciences, Inc. Progressive Supranuclear Palsy Product Portfolio Table 80. Cortice Biosciences, Inc. Recent Development Table 81. Aton Pharma, Inc. Company Information Table 82. Aton Pharma, Inc. Business Overview Table 83. Aton Pharma, Inc. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Aton Pharma, Inc. Progressive Supranuclear Palsy Product Portfolio Table 85. Aton Pharma, Inc. Recent Development Table 86. AlzProtect SAS Company Information Table 87. AlzProtect SAS Business Overview Table 88. AlzProtect SAS Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. AlzProtect SAS Progressive Supranuclear Palsy Product Portfolio Table 90. AlzProtect SAS Recent Development Table 91. AB Science Company Information Table 92. AB Science Business Overview Table 93. AB Science Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. AB Science Progressive Supranuclear Palsy Product Portfolio Table 95. AB Science Recent Development Table 96. North America Progressive Supranuclear Palsy Market Size by Type (2021-2026) & (US$ Million) Table 97. North America Progressive Supranuclear Palsy Market Size by Type (2027-2032) & (US$ Million) Table 98. North America Progressive Supranuclear Palsy Market Size by Application (2021-2026) & (US$ Million) Table 99. North America Progressive Supranuclear Palsy Market Size by Application (2027-2032) & (US$ Million) Table 100. North America Progressive Supranuclear Palsy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Progressive Supranuclear Palsy Market Size by Country (2021-2026) Table 102. North America Progressive Supranuclear Palsy Market Size by Country (2027-2032) Table 103. Europe Progressive Supranuclear Palsy Market Size by Type (2021-2026) & (US$ Million) Table 104. Europe Progressive Supranuclear Palsy Market Size by Type (2027-2032) & (US$ Million) Table 105. Europe Progressive Supranuclear Palsy Market Size by Application (2021-2026) & (US$ Million) Table 106. Europe Progressive Supranuclear Palsy Market Size by Application (2027-2032) & (US$ Million) Table 107. Europe Progressive Supranuclear Palsy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Progressive Supranuclear Palsy Market Size by Country (2021-2026) Table 109. Europe Progressive Supranuclear Palsy Market Size by Country (2027-2032) Table 110. China Progressive Supranuclear Palsy Market Size by Type (2021-2026) & (US$ Million) Table 111. China Progressive Supranuclear Palsy Market Size by Type (2027-2032) & (US$ Million) Table 112. China Progressive Supranuclear Palsy Market Size by Application (2021-2026) & (US$ Million) Table 113. China Progressive Supranuclear Palsy Market Size by Application (2027-2032) & (US$ Million) Table 114. Asia Progressive Supranuclear Palsy Market Size by Type (2021-2026) & (US$ Million) Table 115. Asia Progressive Supranuclear Palsy Market Size by Type (2027-2032) & (US$ Million) Table 116. Asia Progressive Supranuclear Palsy Market Size by Application (2021-2026) & (US$ Million) Table 117. Asia Progressive Supranuclear Palsy Market Size by Application (2027-2032) & (US$ Million) Table 118. Asia Progressive Supranuclear Palsy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Progressive Supranuclear Palsy Market Size by Country (2021-2026) Table 120. Asia Progressive Supranuclear Palsy Market Size by Country (2027-2032) Table 121. South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Type (2021-2026) & (US$ Million) Table 122. South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Type (2027-2032) & (US$ Million) Table 123. South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Application (2021-2026) & (US$ Million) Table 124. South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Application (2027-2032) & (US$ Million) Table 125. South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2021-2026) Table 127. South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Progressive Supranuclear Palsy Product Image Figure 2. Global Progressive Supranuclear Palsy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Progressive Supranuclear Palsy Market Share by Type: 2025 VS 2032 Figure 4. Late Stage Image Figure 5. Clinical Trial Image Figure 6. Early Stage Image Figure 7. Others Image Figure 8. Global Progressive Supranuclear Palsy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Progressive Supranuclear Palsy Market Share by Application: 2025 VS 2032 Figure 10. Clinics Image Figure 11. Hospitals Image Figure 12. Research Institutes Image Figure 13. Others Image Figure 14. Global Progressive Supranuclear Palsy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 16. Global Progressive Supranuclear Palsy Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Progressive Supranuclear Palsy Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Progressive Supranuclear Palsy Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Progressive Supranuclear Palsy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Progressive Supranuclear Palsy Revenue Market Share by Type (2021-2032) Figure 23. Global Progressive Supranuclear Palsy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Progressive Supranuclear Palsy Revenue Market Share by Application (2021-2032) Figure 25. North America Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 26. North America Progressive Supranuclear Palsy Market Share by Type (2021-2032) Figure 27. North America Progressive Supranuclear Palsy Market Share by Application (2021-2032) Figure 28. North America Progressive Supranuclear Palsy Market Share by Country (2021-2032) Figure 29. United States Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 30. Canada Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 32. Europe Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 33. Europe Progressive Supranuclear Palsy Market Share by Type (2021-2032) Figure 34. Europe Progressive Supranuclear Palsy Market Share by Application (2021-2032) Figure 35. Europe Progressive Supranuclear Palsy Market Share by Country (2021-2032) Figure 36. Germany Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 37. France Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 39. Italy Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 40. Russia Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 42. China Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 43. China Progressive Supranuclear Palsy Market Share by Type (2021-2032) Figure 44. China Progressive Supranuclear Palsy Market Share by Application (2021-2032) Figure 45. Asia Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 46. Asia Progressive Supranuclear Palsy Market Share by Type (2021-2032) Figure 47. Asia Progressive Supranuclear Palsy Market Share by Application (2021-2032) Figure 48. Asia Progressive Supranuclear Palsy Market Share by Country (2021-2032) Figure 49. Japan Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 53. India Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 54. Australia Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Progressive Supranuclear Palsy Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Progressive Supranuclear Palsy Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Progressive Supranuclear Palsy Market Share by Country (2021-2032) Figure 59. Brazil Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 64. UAE Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 66. Chile Progressive Supranuclear Palsy Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Late Stage
  • Clinical Trial
  • Early Stage
  • Others
Applications
  • Clinics
  • Hospitals
  • Research Institutes
  • Others
Companies covered
  • Novartis AG
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Biogen Inc.
  • Bristol Myers Squibb (BMS)
  • AbbVie Inc.
  • Acorda Therapeutics Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Cortice Biosciences, Inc.
  • Aton Pharma, Inc.
  • AlzProtect SAS
  • AB Science

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Progressive Supranuclear Palsy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Late Stage
  5. 1.2.3 Clinical Trial
  6. 1.2.4 Early Stage
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Progressive Supranuclear Palsy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Clinics
  11. 1.3.3 Hospitals
  12. 1.3.4 Research Institutes
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Progressive Supranuclear Palsy Growth Trends by Region
  16. 1.5.1 Global Progressive Supranuclear Palsy Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Progressive Supranuclear Palsy Market Size by Region (2021-2026)
  18. 1.5.3 Progressive Supranuclear Palsy Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Progressive Supranuclear Palsy Market Dynamics
  1. 2.1 Progressive Supranuclear Palsy Industry Trends
  2. 2.2 Progressive Supranuclear Palsy Industry Drivers
  3. 2.3 Progressive Supranuclear Palsy Industry Opportunities and Challenges
  4. 2.4 Progressive Supranuclear Palsy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Progressive Supranuclear Palsy Revenue by Company (2021-2026)
  2. 3.2 Global Progressive Supranuclear Palsy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Progressive Supranuclear Palsy Key Company Head office and Area Served
  4. 3.4 Global Progressive Supranuclear Palsy Company, Product Type & Application
  5. 3.5 Global Progressive Supranuclear Palsy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Progressive Supranuclear Palsy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Progressive Supranuclear Palsy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Progressive Supranuclear Palsy Tier 1, Tier 2, and Tier 3
4 Progressive Supranuclear Palsy Market by Type
  1. 4.1 Global Progressive Supranuclear Palsy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Progressive Supranuclear Palsy Market Size by Type (2021-2032)
  3. 4.3 Global Progressive Supranuclear Palsy Market Size Share by Type (2021-2032)
5 Progressive Supranuclear Palsy Market by Application
  1. 5.1 Global Progressive Supranuclear Palsy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Progressive Supranuclear Palsy Market Size by Application (2021-2032)
  3. 5.3 Global Progressive Supranuclear Palsy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis AG Progressive Supranuclear Palsy Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Merck & Co., Inc.
  8. 6.2.1 Merck & Co., Inc. Company Information
  9. 6.2.2 Merck & Co., Inc. Business Overview
  10. 6.2.3 Merck & Co., Inc. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck & Co., Inc. Progressive Supranuclear Palsy Product Portfolio
  12. 6.2.5 Merck & Co., Inc. Recent Developments
  13. 6.3 GlaxoSmithKline plc
  14. 6.3.1 GlaxoSmithKline plc Company Information
  15. 6.3.2 GlaxoSmithKline plc Business Overview
  16. 6.3.3 GlaxoSmithKline plc Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GlaxoSmithKline plc Progressive Supranuclear Palsy Product Portfolio
  18. 6.3.5 GlaxoSmithKline plc Recent Developments
  19. 6.4 Biogen Inc.
  20. 6.4.1 Biogen Inc. Company Information
  21. 6.4.2 Biogen Inc. Business Overview
  22. 6.4.3 Biogen Inc. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Biogen Inc. Progressive Supranuclear Palsy Product Portfolio
  24. 6.4.5 Biogen Inc. Recent Developments
  25. 6.5 Bristol Myers Squibb (BMS)
  26. 6.5.1 Bristol Myers Squibb (BMS) Company Information
  27. 6.5.2 Bristol Myers Squibb (BMS) Business Overview
  28. 6.5.3 Bristol Myers Squibb (BMS) Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bristol Myers Squibb (BMS) Progressive Supranuclear Palsy Product Portfolio
  30. 6.5.5 Bristol Myers Squibb (BMS) Recent Developments
  31. 6.6 AbbVie Inc.
  32. 6.6.1 AbbVie Inc. Company Information
  33. 6.6.2 AbbVie Inc. Business Overview
  34. 6.6.3 AbbVie Inc. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 AbbVie Inc. Progressive Supranuclear Palsy Product Portfolio
  36. 6.6.5 AbbVie Inc. Recent Developments
  37. 6.7 Acorda Therapeutics Inc.
  38. 6.7.1 Acorda Therapeutics Inc. Company Information
  39. 6.7.2 Acorda Therapeutics Inc. Business Overview
  40. 6.7.3 Acorda Therapeutics Inc. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Acorda Therapeutics Inc. Progressive Supranuclear Palsy Product Portfolio
  42. 6.7.5 Acorda Therapeutics Inc. Recent Developments
  43. 6.8 Teva Pharmaceutical Industries Ltd.
  44. 6.8.1 Teva Pharmaceutical Industries Ltd. Company Information
  45. 6.8.2 Teva Pharmaceutical Industries Ltd. Business Overview
  46. 6.8.3 Teva Pharmaceutical Industries Ltd. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Teva Pharmaceutical Industries Ltd. Progressive Supranuclear Palsy Product Portfolio
  48. 6.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  49. 6.9 Cortice Biosciences, Inc.
  50. 6.9.1 Cortice Biosciences, Inc. Company Information
  51. 6.9.2 Cortice Biosciences, Inc. Business Overview
  52. 6.9.3 Cortice Biosciences, Inc. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Cortice Biosciences, Inc. Progressive Supranuclear Palsy Product Portfolio
  54. 6.9.5 Cortice Biosciences, Inc. Recent Developments
  55. 6.10 Aton Pharma, Inc.
  56. 6.10.1 Aton Pharma, Inc. Company Information
  57. 6.10.2 Aton Pharma, Inc. Business Overview
  58. 6.10.3 Aton Pharma, Inc. Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Aton Pharma, Inc. Progressive Supranuclear Palsy Product Portfolio
  60. 6.10.5 Aton Pharma, Inc. Recent Developments
  61. 6.11 AlzProtect SAS
  62. 6.11.1 AlzProtect SAS Company Information
  63. 6.11.2 AlzProtect SAS Business Overview
  64. 6.11.3 AlzProtect SAS Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 AlzProtect SAS Progressive Supranuclear Palsy Product Portfolio
  66. 6.11.5 AlzProtect SAS Recent Developments
  67. 6.12 AB Science
  68. 6.12.1 AB Science Company Information
  69. 6.12.2 AB Science Business Overview
  70. 6.12.3 AB Science Progressive Supranuclear Palsy Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 AB Science Progressive Supranuclear Palsy Product Portfolio
  72. 6.12.5 AB Science Recent Developments
7 North America
  1. 7.1 North America Progressive Supranuclear Palsy Market Size (2021-2032)
  2. 7.2 North America Progressive Supranuclear Palsy Market Size by Type
  3. 7.2.1 North America Progressive Supranuclear Palsy Market Size by Type (2021-2026)
  4. 7.2.2 North America Progressive Supranuclear Palsy Market Size by Type (2027-2032)
  5. 7.2.3 North America Progressive Supranuclear Palsy Market Share by Type (2021-2032)
  6. 7.3 North America Progressive Supranuclear Palsy Market Size by Application
  7. 7.3.1 North America Progressive Supranuclear Palsy Market Size by Application (2021-2026)
  8. 7.3.2 North America Progressive Supranuclear Palsy Market Size by Application (2027-2032)
  9. 7.3.3 North America Progressive Supranuclear Palsy Market Share by Application (2021-2032)
  10. 7.4 North America Progressive Supranuclear Palsy Market Size by Country
  11. 7.4.1 North America Progressive Supranuclear Palsy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Progressive Supranuclear Palsy Market Size by Country (2021-2026)
  13. 7.4.3 North America Progressive Supranuclear Palsy Market Size by Country (2027-2032)
  14. 7.4.4 North America Progressive Supranuclear Palsy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Progressive Supranuclear Palsy Market Size (2021-2032)
  2. 8.2 Europe Progressive Supranuclear Palsy Market Size by Type
  3. 8.2.1 Europe Progressive Supranuclear Palsy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Progressive Supranuclear Palsy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Progressive Supranuclear Palsy Market Share by Type (2021-2032)
  6. 8.3 Europe Progressive Supranuclear Palsy Market Size by Application
  7. 8.3.1 Europe Progressive Supranuclear Palsy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Progressive Supranuclear Palsy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Progressive Supranuclear Palsy Market Share by Application (2021-2032)
  10. 8.4 Europe Progressive Supranuclear Palsy Market Size by Country
  11. 8.4.1 Europe Progressive Supranuclear Palsy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Progressive Supranuclear Palsy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Progressive Supranuclear Palsy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Progressive Supranuclear Palsy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Progressive Supranuclear Palsy Market Size (2021-2032)
  2. 9.2 China Progressive Supranuclear Palsy Market Size by Type
  3. 9.2.1 China Progressive Supranuclear Palsy Market Size by Type (2021-2026)
  4. 9.2.2 China Progressive Supranuclear Palsy Market Size by Type (2027-2032)
  5. 9.2.3 China Progressive Supranuclear Palsy Market Share by Type (2021-2032)
  6. 9.3 China Progressive Supranuclear Palsy Market Size by Application
  7. 9.3.1 China Progressive Supranuclear Palsy Market Size by Application (2021-2026)
  8. 9.3.2 China Progressive Supranuclear Palsy Market Size by Application (2027-2032)
  9. 9.3.3 China Progressive Supranuclear Palsy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Progressive Supranuclear Palsy Market Size (2021-2032)
  2. 10.2 Asia Progressive Supranuclear Palsy Market Size by Type
  3. 10.2.1 Asia Progressive Supranuclear Palsy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Progressive Supranuclear Palsy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Progressive Supranuclear Palsy Market Share by Type (2021-2032)
  6. 10.3 Asia Progressive Supranuclear Palsy Market Size by Application
  7. 10.3.1 Asia Progressive Supranuclear Palsy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Progressive Supranuclear Palsy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Progressive Supranuclear Palsy Market Share by Application (2021-2032)
  10. 10.4 Asia Progressive Supranuclear Palsy Market Size by Country
  11. 10.4.1 Asia Progressive Supranuclear Palsy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Progressive Supranuclear Palsy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Progressive Supranuclear Palsy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Progressive Supranuclear Palsy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Progressive Supranuclear Palsy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Progressive Supranuclear Palsy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Progressive Supranuclear Palsy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Progressive Supranuclear Palsy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst